| | Business Summary | | Hycor
Biomedical,
Inc.
is
engaged
in
the
research,
development,
manufacture
and
sale
of
medical
and
diagnostic
products
with
a
focus
on
allergy
and
autoimmune
testing
and
urinalysis
products.
The
Company
operates
two
wholly
owned
subsidiaries,
Hycor
Biomedical
GmbH
and
Hycor
Biomedical,
LTD.
Hycor
GmbH
primarily
manufactures
and
sells
allergy
diagnostic
products
in
Europe.
Hycor
Ltd.
develops,
manufactures
and
markets
a
broad
line
of
test
kits
for
the
diagnosis
of
autoimmune
disease. | | More
from
Market Guide: Expanded
Business Description |
| | Financial Summary | | HYBD
is
engaged
in
the
research,
development,
manufacturing
and
marketing
of
medical
diagnostic
products
throughout
the
US
and
foreign
countries.
HYBD
products
include
the
KOVA
Urinalysis
System
and
the
allergy
diagnostic
product
line.
For
the
six
months
ended
6/30/01,
sales
fell
5%
to
$8.5
million.
Net
income
fell
36%
to
$313
thousand.
Results
reflect
unfavorable
currency
translation
effects
and
lower
margins
due
to
reduced
revenues. | | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| Samuel Anderson, 65
Chairman | -- | -- | J. David Tholen, 56
Pres,
CEO, Director | $298K | $630K | Reginald Jones, 54
CFO,
Sr. VP, Treasurer, Sec., Director | 277K | 752K | Mary Jo Deal, 45
Sr.
VP, Marketing and Sales | 229K | 147K | Nelson Thune, 55
Sr.
VP - Operation and Planning | 244K | 590K | | Dollar
amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors:
Expanded
List, Bios,
Compensation,
Options
|
|
![[one-year price graph]](http://chart.yahoo.com/c/0b/h/hybd.gif)